Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ning Ma, Lei Zhang, Wufang Zhang, Yingying He, Chong Ye & Xin Li. (2023) Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review. Neuropsychiatric Disease and Treatment 19, pages 1987-2006.
Read now
Read now
Tianmei Si, Jianmin Zhuo, Yu Feng, Huafei Lu, Di Hong & Lili Zhang. (2019) Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia. Neuropsychiatric Disease and Treatment 15, pages 1685-1694.
Read now
Read now
Articles from other publishers (3)
Lefan Jin, Yun Chen, Junli Zhu, Qingzhi Huang, Bin Li, Ying Xu, Rui Xi & Wei Lu. (2021) The Willingness of Community Psychiatric Management Physicians to Preferentially Recommend Long-Acting Injections in Beijing. Frontiers in Public Health 9.
Crossref
Crossref
Dasom Lee, Boung Chul Lee, Soo-Hee Choi, Do-Hyung Kang, Duk-In Jon & Myung Hun Jung. (2020) Effects of Paliperidone Palmitate on Healthcare Utilization and Costs for Patients with Schizophrenia: A Claim-based Mirror-image Study in South Korea. Clinical Psychopharmacology and Neuroscience 18:2, pages 303-310.
Crossref
Crossref
José Miguel Meca García, Miguel Soto Ontoso, Eliana Gómez Padrón, María Rosa Sanchez-Waisen Hernández & Yaiza Rojas Vallejo. (2020) Estudio observacional sobre los efectos del palmitato de paliperidona inyectable mensual sobre la hospitalización y asistencia urgente. Psiquiatría Biológica 27:2, pages 43-46.
Crossref
Crossref